News

Dechra extends otitis externa product range with the launch of DuOtic otic gel

June 23 2025 - Dechra has extended its otitis externa product range with the launch of DuOtic otic gel, the first licensed steroid and antifungal combination for the treatment of otitis externa in dogs associated with susceptible strains of Malassezia pachydermatis.

Jesper Nordengaard appointed as CEO of Dechra

May 16, 2024 -Dechra Pharmaceuticals Limited today announces the appointment of Jesper Nordengaard as its CEO and retirement of Ian Page effective June 10, 2024.

Dechra scoop three awards at the Veterinary Marketing Association awards

Dechra has won a hat trick of awards at the prestigious Veterinary Marketing Association (VMA) Awards 2023 which were held on Friday 17 March at the Royal Lancaster Hotel in London.

Dechra takes on distribution of Ketodolor®

Dechra has taken on the distribution of Ketodolor®, the non-steroidal anti-inflammatory (NSAID) and anti-rheumatic product for cattle, pigs and horses.